KD

Kanti Devi Rao

Director Director DIN 03574920
DIN 03574920 First appointment Oct 2004 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2004
Shareholding value Locked Premium profile

About Kanti Devi Rao

Kanti Devi Rao has 21 years in corporate governance. Formerly with 1 company, such as Ginsburg Drugs And Formulations Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03574920
Primary Designation Director
First Appointment 11 Oct 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 11 Oct 2004 2004 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ginsburg Drugs And Formulations Private Limited
Premium access

Shareholding and investment profile for Kanti Devi Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanti Devi Rao

Kanti Devi Rao has 21 years in corporate governance. Formerly with 1 company, such as Ginsburg Drugs And Formulations Private Limited. Engaged in General Business. Contributes to corporate operations.

Kanti Devi Rao is associated with 0 companies as a director.

Kanti Devi Rao has expertise in General Business.

Kanti Devi Rao has 21 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available